We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
176
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$20.3M 0.13%
1,215,272
– –
SPLK
177
DELISTED
Splunk Inc
SPLK
$20.2M 0.13%
174,410
-5,730
-3% -$800K
EW icon
178
Edwards Lifesciences
EW
$47.8B
$19.9M 0.13%
153,540
+38,591
+34% +$4.5M
ALLY icon
179
Ally Financial
ALLY
$13.3B
$19.6M 0.13%
412,204
+31,633
+8% +$1.57M
ITW icon
180
Illinois Tool Works
ITW
$81.9B
$19.4M 0.12%
78,558
-35,143
-31% -$8.17M
LULU icon
181
lululemon athletica
LULU
$13.4B
$19.3M 0.12%
49,342
-3,351
-6% -$1.43M
CRIS icon
182
Curis
CRIS
$9.14M
$19.3M 0.12%
10,137
+2,581
+34% +$6.14M
BMY icon
183
Bristol-Myers Squibb
BMY
$128B
$19.2M 0.12%
308,591
-72,359
-19% -$4.24M
GBT
184
DELISTED
Global Blood Therapeutics, Inc.
GBT
$19M 0.12%
648,339
+314,298
+94% +$9.74M
XLNX
185
DELISTED
Xilinx Inc
XLNX
$18.7M 0.12%
88,213
-36,159
-29% -$7.13M
TREX icon
186
Trex
TREX
$4.57B
$18.7M 0.12%
138,439
-60,293
-30% -$7.24M
EXAS
187
DELISTED
Exact Sciences
EXAS
$18.4M 0.12%
236,833
+5,974
+3% +$527K
MGLN
188
DELISTED
Magellan Health Services, Inc.
MGLN
$18.4M 0.12%
193,817
– –
KDNY
189
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$18M 0.12%
1,104,902
+202,365
+22% +$2.88M
EQR icon
190
Equity Residential
EQR
$25.2B
$17.9M 0.11%
198,303
+63,066
+47% +$5.43M
FRTA
191
DELISTED
Forterra, Inc
FRTA
$17.5M 0.11%
734,897
– –
LH icon
192
Labcorp
LH
$24.7B
$17.4M 0.11%
64,607
+4,434
+7% +$1.1M
Y
193
DELISTED
Alleghany Corp
Y
$17.3M 0.11%
25,912
-6,786
-21% -$4.52M
IOVA icon
194
Iovance Biotherapeutics
IOVA
$2.19B
$17.1M 0.11%
896,364
+47,712
+6% +$1.05M
BNS icon
195
Scotiabank
BNS
$106B
$16.9M 0.11%
239,020
-267,196
-53% -$17.7M
MRSH
196
Marsh
MRSH
$87.5B
$16.9M 0.11%
97,408
+61,251
+169% +$10.2M
XENE icon
197
Xenon Pharmaceuticals
XENE
$6.36B
$16.6M 0.11%
530,511
-185,211
-26% -$5.53M
RMD icon
198
ResMed
RMD
$29.5B
$16.5M 0.11%
63,232
+45,056
+248% +$11.7M
INBX
199
DELISTED
Inhibrx, Inc. Common Stock
INBX
$16.4M 0.1%
+375,326
New +$15M
BBY icon
200
Best Buy
BBY
$18.6B
$16.4M 0.1%
160,985
-16,078
-9% -$1.83M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.